Protection against Borreliella burgdorferi infection mediated by a synthetically engineered DNA vaccine.
Protection against Borreliella burgdorferi infection mediated by a synthetically engineered DNA vaccine.
复制标题
DOI:
10.1080/21645515.2020.1789408
复制
发表时间:
2020-09-01
影响因子:
4.8
通讯作者:
Smith TRF
中科院分区:
文献类型:
--
作者:
Guibinga GH;Sahay B;Brown H;Cooch N;Chen J;Yan J;Reed C;Mishra M;Yung B;Pugh H;Schultheis K;Esquivel RN;Weiner DB;Humeau LH;Broderick KE;Smith TRF
Lyme disease is the most common vector-borne disease in North America. The etiological agent is the spirochete Borreliella burgdorferi, transmitted to mammalian hosts by the Ixodes tick. In recent years there has been an increase in the number of cases of Lyme disease. Currently, there is no vaccine on the market for human use. We describe the development of a novel synthetically engineered DNA vaccine, pLD1 targeting the outer-surface protein A (OspA) of Borreliella burgdorferi. Immunization of C3 H/HeN mice with pLD1 elicits robust humoral and cellular immune responses that confer complete protection against a live Borreliella burgdorferi bacterial challenge. We also assessed intradermal (ID) delivery of pLD1 in Hartley guinea pigs, demonstrating the induction of robust and durable humoral immunity that lasts at least 1 year. We provide evidence of the potency of pLD1 by showing that antibodies targeting the OspA epitopes which have been associated with protection are prominently raised in the immunized guinea pigs. The described study provides the basis for the advancement of pDL1 as a potential vaccine for Lyme disease control.
登录
查看更多内容
影响因子:
6.2
作者:
Bode C;Zhao G;Steinhagen F;Kinjo T;Klinman DM
通讯作者:
Klinman DM
影响因子:
7
作者:
Sardesai NY;Weiner DB
通讯作者:
Weiner DB
影响因子:
6.7
作者:
Sahay B;Patsey RL;Eggers CH;Salazar JC;Radolf JD;Sellati TJ
通讯作者:
Sellati TJ
影响因子:
3.1
作者:
Liang, FT;Yan, J;Fikrig, E
通讯作者:
Fikrig, E
影响因子:
3.1
作者:
Golde, WT;Piesman, J;Frantz, JC
通讯作者:
Frantz, JC